LONDON--(BUSINESS WIRE)--Technavio has been monitoring the respiratory syncytial virus diagnostics market and it is poised to grow by $ 585.17 million during 2020-2024, progressing at a CAGR of almost 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Latest Free Sample Report on COVID-19 Impact
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Quidel Corp., Seegene Inc., and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The increase in product launches has been instrumental in driving the growth of the market. However, the high costs of RSV diagnostic products might hamper market growth.
Respiratory Syncytial Virus Diagnostics Market 2020-2024 : Segmentation
Respiratory Syncytial Virus Diagnostics Market is segmented as below:
-
Product
- Consumables
- Systems
-
Geography
- North America
- Europe
- Asia
- ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43463
Respiratory Syncytial Virus Diagnostics Market 2020-2024 : Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our respiratory syncytial virus diagnostics market report covers the following areas:
- Respiratory Syncytial Virus Diagnostics Market size
- Respiratory Syncytial Virus Diagnostics Market trends
- Respiratory Syncytial Virus Diagnostics Market industry analysis
This study identifies technological advancements as one of the prime reasons driving the respiratory syncytial virus diagnostics market growth during the next few years.
Respiratory Syncytial Virus Diagnostics Market 2020-2024 : Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the respiratory syncytial virus diagnostics market, including some of the vendors such as Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Quidel Corp., Seegene Inc., and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the respiratory syncytial virus diagnostics market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Respiratory Syncytial Virus Diagnostics Market 2020-2024 : Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist respiratory syncytial virus diagnostics market growth during the next five years
- Estimation of the respiratory syncytial virus diagnostics market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the respiratory syncytial virus diagnostics market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of respiratory syncytial virus diagnostics market vendors
Table Of Contents :
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five Force Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Consumables - Market size and forecast 2019-2024
- Systems - Market size and forecast 2019-2024
- Market opportunity by Product
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Volume Driver – demand led growth
Market Challenges
Market Trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Quidel Corp.
- Seegene Inc.
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
